In the present investigation, we leveraged integrative genomic analyses to analyse large‐scale GWAS data and prioritized 438 COVID‐19‐relevant risk genes, including IFNAR2, CCR1, ICAM1, VIPR2, and IL10RB, which are attributable to search genuine drug targets for COVID‐19 severities. Here, VIPR2 is linked to COVID-19.